Filing Details

Accession Number:
0001144204-15-041253
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-06 21:00:15
Reporting Period:
2015-07-01
Filing Date:
2015-07-06
Accepted Time:
2015-07-06 21:00:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1270073 Intercept Pharmaceuticals Inc ICPT Pharmaceutical Preparations (2834) 223868459
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559570 David Shapiro C/O Intercept Pharmaceuticals, Inc.
450 W. 15Th Street, Suite 505
New York NY 10011
Cmo And Evp - Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-07-01 3,500 $8.67 22,014 No 4 M Direct
Common Stock Disposition 2015-07-01 1,000 $237.64 21,014 No 4 S Direct
Common Stock Disposition 2015-07-01 1,902 $238.51 19,112 No 4 S Direct
Common Stock Disposition 2015-07-01 398 $239.32 18,714 No 4 S Direct
Common Stock Disposition 2015-07-01 381 $240.59 18,333 No 4 S Direct
Common Stock Disposition 2015-07-01 100 $241.81 18,233 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock Disposition 2015-07-01 3,500 $0.00 3,500 $8.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
22,794 2020-08-16 No 4 M Direct
Footnotes
  1. The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 25, 2014.
  2. All shares underlying this option have vested.
  3. This transaction was executed in multiple trades at prices ranging from $237.0100 to $238.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $238.0250 to $239.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $239.1350 to $239.6100. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $240.3300 to $241.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.